{"id":"F2015L01353","name":"Health Insurance (Pharmacogenetic Testing – RAS (KRAS and NRAS)) Revocation Determination 2015","slug":"health-insurance-pharmacogenetic-testing-ras-kras-and-nras-revocation-determination-2015","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":438419,"registerId":"F2015L01353-fast-fetch-1775954860495","compilationNumber":null,"startDate":"2026-04-12","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Health Insurance (Pharmacogenetic Testing – RAS (KRAS and NRAS)) Revocation Determination 2015","content":"---\nmeta-content-style-type: text/css\nmeta-content-type: application/xhtml+xml; charset=utf-8\nmeta-generator: Aspose.Words for .NET 20.2\n---\n\n?xml version=\"1.0\" encoding=\"utf-8\" standalone=\"no\"?>\n\n![](image.001.png)\n\nHealth Insurance (Pharmacogenetic Testing – RAS (KRAS and NRAS)) Revocation Determination 2015\n\n \n\nI, CATHERINE RULE, delegate of the Minister for Health, make this Determination under subsection 3C(1) of the Health Insurance Act 1973.\n\nDated    24 August 2015\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n____________________________________\n\nCATHERINE RULE\n\nFIRST ASSISTANT SECRETARY\n\nMEDICAL BENEFITS DIVISION\n\n \n\n \n\n \n\n# 1.                         Name of Determination\n\nThis Determination is the Health Insurance (Pharmacogenetic Testing – RAS (KRAS and NRAS)) Revocation Determination 2015\n\n# 2.                       Commencement\n\nThis Determination commences on 1 September 2015.\n\n# 3.                       Revocation\n\nThis Determination revokes the Health Insurance (Pharmacogenetic Testing – RAS (KRAS and NRAS)) Determination 2014.\n\n \n\n \n\n \n\n \n","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1977},"content_quality":"ok","complexity_score":1,"scope_assessment":{"changed":false,"description":"This instrument serves a narrow administrative purpose to revoke a prior determination. It does not expand beyond its intended function of cancelling the 2014 rules regarding pharmacogenetic testing rebates."},"complexity_factors":["Extremely brief three-section structure (Name, Commencement, Revocation)","Single operative provision performing one action (revocation)","No defined terms or interpretation section","No cross-references to substantive legislative provisions beyond the enabling Act","No conditional logic, exceptions, or administrative procedures"],"plain_english_summary":"This determination **cancels a previous Medicare rule** about genetic testing for cancer treatment.\n\nIt revokes the *Health Insurance (Pharmacogenetic Testing – RAS (KRAS and NRAS)) Determination 2014*, which had set out how Medicare would subsidise (pay for) specific genetic tests. These tests look for mutations in **RAS genes** (KRAS and NRAS) to help doctors work out whether certain cancer patients will benefit from particular targeted therapies.\n\n**What this means:**\n- The specific Medicare funding arrangement created in 2014 for these genetic tests is now removed\n- Patients, doctors, and pathology services will need to use different arrangements to access or fund these tests (if other arrangements exist)\n\n**Who is affected:**\n- Cancer patients who may need genetic testing to guide treatment decisions (particularly for colorectal cancer)\n- Oncologists prescribing these tests and pathology laboratories conducting them\n\nThis is an administrative instrument that removes a previous subsidy rule without replacing it."}},"importantCases":[],"_links":{"self":"/api/acts/health-insurance-pharmacogenetic-testing-ras-kras-and-nras-revocation-determination-2015","history":"/api/acts/health-insurance-pharmacogenetic-testing-ras-kras-and-nras-revocation-determination-2015/history","analysis":"/api/acts/health-insurance-pharmacogenetic-testing-ras-kras-and-nras-revocation-determination-2015/analysis","conflicts":"/api/acts/health-insurance-pharmacogenetic-testing-ras-kras-and-nras-revocation-determination-2015/conflicts","importantCases":"/api/acts/health-insurance-pharmacogenetic-testing-ras-kras-and-nras-revocation-determination-2015/important-cases","documents":"/api/acts/health-insurance-pharmacogenetic-testing-ras-kras-and-nras-revocation-determination-2015/documents"}}